A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 2
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · TRIPLE
- Evidence population
- Human clinical study registration
- Participants
- 31
- Population
- ALL · 55 Years to 75 Years
- Duration
- 2018-09-19 to 2020-03-11
- Intervention
- Methylphenidate; Placebo; CogniPlus software; Pseudo cognitive training
- Comparator
- Not reported
- Outcomes measured
- The difference of the average response time to a choice task at inclusion and at the end of treatment (after 6 weeks) —…; Change from baseline the composite cognitive functions — Baseline, at 6 weeks, at 12 weeks; Change from baseline of the results to task on a driving simulator — Baseline, at 6 weeks, at 12 weeks; Behavior Rating Inventory of Executive Function (BRIEF-A) — Baseline, at 6 weeks, at 12 weeks; Hospital Anxiety and Depression scale (HAD) — Baseline, at 6 weeks, at 12 weeks; Number of undesirable effects of treatment — at 2 weeks, at 4 weeks, at 6 weeks, at 12 weeks; Change from baseline the parameters of structured cognitive training (CogniPlus®) — Baseline, at 6 weeks, at 12 weeks; Resting state EEG — Baseline, at 6 weeks, at 12 weeks; resting state functional MRI — Baseline, at 6 weeks, at 12 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cognitive training · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.